Coronavirus (COVID-19) vaccine certification: evidence paper update

Annex D: Bibliography

^[207]

Aldridge R, W, et al. Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort. (2021) medRxiv Preprint. Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort | medRxiv

Andrews N, et al. Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study. (2021) medRxiv Preprint. Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study | medRxiv

Aranzales, I., et al. Scientists have favourable opinions on immunity certificates but raise concerns regarding fairness and inequality. (2021) Scientific reports. Scientists have favorable opinions on immunity certificates but raise concerns regarding fairness and inequality (nature.com)

Baisheng, L., Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. (2021) medRxiv Preprint. Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant | medRxiv

Barda N, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. (2021) The Lancet. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet

Brown, C.M, et al., Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings—Barnstable County, Massachusetts, July 2021. (2021) Morbidity and Mortality Weekly Report, Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021 - PubMed (nih.gov)

Centers for Disease Control and Prevention (CDC). Improving communications around vaccine breakthrough and vaccine effectiveness 29 July 2021 Presentation here: Improving communications around vaccine breakthrough and vaccine effectiveness, CDC, 29 July 2021

Chief Economist Directorate. GDP Monthly Estimate: July 2021 (22 September 2021) Report here: https://www.gov.scot/publications/monthly-gdp-july-2021/

Chief Economist Directorate. BICS weighted Scotland estimates: data to wave 38 (17 September 2021) Report here: BICS weighted Scotland estimates: data to wave 38 - gov.scot (www.gov.scot)

Chemaitelly H, et al. Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar. (2021) The New England Journal of Medicine Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM

Chen, L.H., et al. COVID-19 immunity passport to ease travel restrictions? (2020) Journal of travel medicine, COVID-19 Immunity Passport to Ease Travel Restrictions? | Journal of Travel Medicine | Oxford Academic (oup.com)

Chia, P.Y., et al. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study. (2021) medRxiv Preprint. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study | medRxiv

Christensen, P.A., Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas. (2021) medRxiv Preprint. Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas | medRxiv

Department for Digital, Culture, Media & Sport. Events Research Programme Phases I, II and III data release. Reports here: Events Research Programme Phases I, II and III data release - GOV.UK (www.gov.uk)

Department of Health and Social Care. Asymptomatic testing for SARS-CoV-2 using antigen-detecting lateral flow devices (7 July 2021). Report here: Asymptomatic testing for SARS-CoV-2 using antigen-detecting lateral flow devices: evidence from performance data October 2020 – May 2021 (publishing.service.gov.uk)

Dumbrava, C and de Groot, D., EU Covid-19 certificate. A tool to help restore the free movement of people across the European Union (2021) EU Covid-19 certificate (europa.eu)

ECDC 26 October 2021 Options for the use of rapid antigen tests for COVID-19 in the EU/EEA - first update (europa.eu)

Elliot, P. REACT-1 round 13 final report: exponential growth, high prevalence of SARS-CoV-2 and vaccine effectiveness associated with Delta variant in England during May to July 2021. (2021) Imperial College London. Spiral: REACT-1 round 13 final report: exponential growth, high prevalence of SARS-CoV-2 and vaccine effectiveness associated with Delta variant in England during May to July 2021 (imperial.ac.uk)

Environmental Modelling Group (EMG), Public Health England (PHE). Aerosol and Droplet Generation from Singing, Wind Instruments (SWI) and Performance Activities. (2020) Report here: PHE/EMG: Aerosol and droplet generation from singing, wind instruments and performance activities, 13 August 2020 - GOV.UK (www.gov.uk)

Environmental Modelling Group (EMG). Application of physical distancing and fabric face coverings in mitigating the B117 variant SARS-CoV-2 virus in public, workplace and community, 13 January 2021. (2021) Report here: EMG: Application of physical distancing and fabric face coverings in mitigating the B117 variant SARS-CoV-2 virus in public, workplace and community, 13 January 2021 - GOV.UK (www.gov.uk)

Environmental Modelling Group (EMG), Scientific Pandemic Influenza Group on Modelling (SPI-M), Scientific Pandemic Insights Group on Behaviours (SPI-B). Considerations in implementing long-term 'baseline' Non-Pharmaceutical Interventions. (2021) Report here: EMG, SPI-M and SPI-B: Considerations in implementing long-term 'baseline' NPIs, 22 April 2021 - GOV.UK (www.gov.uk)

Environmental Modelling Group, Transmission Group Report. Insights on transmission of COVID-19 with a focus on the hospitality, retail and leisure sector (8 April 2021) Report here: EMG Transmission Group: Insights on transmission of COVID-19 with a focus on the hospitality, retail and leisure sector, 8 April 2021 - GOV.UK (www.gov.uk)

Environmental Modelling Group (EMG). Role of ventilation in controlling SARS-CoV-2 transmission, 30 September 2020. (2020) Report here: EMG: Role of ventilation in controlling SARS-CoV-2 transmission, 30 September 2020 - GOV.UK (www.gov.uk)

Environmental Modelling Group (EMG). Transmission of SARS-CoV-2 and Mitigating Measures. (2021) Report here: Transmission of SARS-CoV-2 and Mitigating Measures - update, 4 June 2020 - GOV.UK (www.gov.uk)

Eyre S.W. et al. The impact of SARS-CoV-2 vaccination on Alpha & Delta variant transmission. (2021) medRxiv The impact of SARS-CoV-2 vaccination on Alpha & Delta variant transmission | medRxiv

Garrett, P (2021). Public attitudes to immunity passports | Pursuit by The University of Melbourne (unimelb.edu.au)

Goldberg Y, et al. Waning Immunity after the BNT162b2 Vaccine in Israel. (2021) The New England Journal of Medicine Waning Immunity after the BNT162b2 Vaccine in Israel | NEJM

Griffin, J.B., et al. SARS-CoV-2 infections and hospitalizations among persons aged≥ 16 years, by vaccination status—Los Angeles County, California, May 1–July 25, 2021. (2021) Morbidity and Mortality Weekly Report, SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021 (nih.gov)

Griffin, S., Covid-19: Fully vaccinated people can carry as much delta virus as unvaccinated people, data indicate. (2021) BMJ Covid-19: Fully vaccinated people can carry as much delta virus as unvaccinated people, data indicate | The BMJ

Hall, M.A. and Studdert, D.M., "Vaccine Passport" Certification—Policy and Ethical Considerations. (2021) New England Journal of Medicine. "Vaccine Passport" Certification — Policy and Ethical Considerations | NEJM

Harris, R.J., et al. Impact of vaccination on household transmission of SARS-COV-2 in England. (2021) medRxiv, Impact of vaccination on household transmission of SARS-COV-2 Harris et al

HM Government. Covid-19 response: Autumn and winter plan. (2021) Report here: COVID-19 RESPONSE: AUTUMN AND WINTER PLAN (publishing.service.gov.uk)

Ipsos. Global views on personal health data and vaccine passports. (2021) Presentation here: Présentation PowerPoint (ipsos.com)

Juniper Consortium (2021). Report here: S1392_Juniper_Consortium_Control_Options_for_Mitigating_a_Rapid_Rise_in_Infection.pdf (publishing.service.gov.uk)

Ke, R., et al., Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution. (2021) medRxiv Preprint. Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution | medRxiv

Kosciejew, M.R.H., COVID-19 immunity (or vaccine) passports: a documentary overview and analysis of regimes of health verification within the coronavirus pandemic. (2021) Journal of Documentation. COVID-19 immunity (or vaccine) passports: a documentary overview and analysis of regimes of health verification within the coronavirus pandemic | Emerald Insight

Layan, M., et al. Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study. (2021) medRxiv Preprint. Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study | medRxiv

Leber et al. (2021) The Lancet Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2) - EClinicalMedicine (thelancet.com)

Li, B., et al. Viral infection and transmission in a large well-traced outbreak caused by the Delta SARS-CoV-2 variant. (2021) medRxiv Preprint. Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant | medRxiv

Luo, C.H., Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals. (2021) medRxiv Preprint. Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals (nih.gov)

Mills M and Rüttenauer T, (2021). The impact of mandatory COVID-19 certificates on vaccine uptake: Synthetic Control Modelling of Six Countries

Mizrahi B, et al. Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. (2021) Nature Communications Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine | Nature Communications

Mlcochova, P., SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough. (2021) NaturePortfolio In Review. SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough | Research Square

Musser, J.M., et al. Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas. (2021) medRxiv Preprint. Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas | medRxiv

Nalubola, S., Vaccine Passports and COVID-19: Ethical, Scientific, and Practical Considerations. (2021) Roundtable J. Health Policy, Vaccine Passports and COVID-19: Ethical, Scientific, and Practical Considerations – The Roundtable Journal on Health Policy

Niculaescu, C. E., Sassoon, I., Avila, I. C. L., Colak, O., Jun, G. T., & Balatsoukas, P. (2021). Why one size fits all is not enough when designing immunity certificates for domestic use: a UK wide cross-sectional online survey. medRxiv.(pre-print)

ONS – Coronavirus (COVID-19) Infection Survey 18 October 2021. Report here: Coronavirus (COVID-19) Infection Survey Technical Article: Impact of vaccination on testing positive in the UK - Office for National Statistics

Osama, T., et al. Covid-19 vaccine passports: access, equity, and ethics. (2021) BMJ Covid-19 vaccine passports: access, equity, and ethics | The BMJ

Peterson et al. (2021) PMC Recalibrating SARS-CoV-2 Antigen Rapid Lateral Flow Test Relative Sensitivity from Validation Studies to Absolute Sensitivity for Indicating Individuals Shedding Transmissible Virus (2021)

Pfizer And BioNTech Announce Phase 3 Trial Data Showing High Efficacy of A Booster Dose Of Their COVID-19 Vaccine (2021), Press release here: Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine | Pfizer

Pouwels, K., et al. Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. (2021) medRxiv. Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK (medrxiv.org)

Prunas, O., Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel. (2021) medRxiv Preprint. Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel | medRxiv

Public Health England, COVID-19 vaccine surveillance report (2021). Weekly reports here: COVID-19 vaccine surveillance reports - GOV.UK (www.gov.uk)

Public Health England, for the Scientific Advisory Group for Emergencies (SAGE). Duration of protection of COVID-19 vaccines against clinical disease (9 September 2021). Report here: PHE: Duration of protection of COVID-19 vaccines against clinical disease, 9 September 2021 - GOV.UK (www.gov.uk)

Public Health England. Risk assessment for SARS-CoV-2 variant Delta: 8 July 2021. (2021) Report here: Investigation of SARS-CoV-2 variants of concern: variant risk assessments - GOV.UK (www.gov.uk)

Public Health England. SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing. (2021) Reports here: Investigation of SARS-CoV-2 variants of concern: technical briefings - GOV.UK (www.gov.uk)

Public Health England. Investigation of SARS-CoV-2 variants of concern: variant risk assessments. Reports here: Investigation of SARS-CoV-2 variants of concern: variant risk assessments - GOV.UK (www.gov.uk)

Public Health England, Transmission Group. Factors contributing to risk of SARS-CoV-2 transmission in various settings (26 November 2020). Report here: PHE: Factors contributing to risk of SARS-CoV2 transmission in various settings, 26 November 2020 - GOV.UK (www.gov.uk)

Public Health Scotland. Covid-19 Statistical Report (2021). Weekly reports here: Show all releases - Publications - Public Health Scotland

Riemersma, K.K., et al. Shedding of Infectious SARS-CoV-2 Despite Vaccination when the Delta Variant is Prevalent-Wisconsin, July 2021. (2021) medRxiv Preprint, Shedding of Infectious SARS-CoV-2 Despite Vaccination when the Delta Variant is Prevalent - Wisconsin, July 2021 | medRxiv (contiamoci.eu)

Riley, S,. et al. REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021. (2021) medRxiv Preprint. REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021 | medRxiv

Ruian Ke, P. Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution. (2021) medRxiv Preprint, Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution | medRxiv

Scientific Advisory Group for Emergencies (SAGE). Sixtieth SAGE meeting on COVID-19 – 1 October 2020. (2020) Report here: SAGE 60 minutes: Coronavirus (COVID-19) response, 1 October 2020 - GOV.UK (www.gov.uk)

Scientific Advisory Group for Emergencies (SAGE) SPI-B, SPI-M and EMG: Considerations for potential impact of Plan B measures (13 October 2021). Report here: S1393_SPI-B_SPI-M_EMG_Considerations_for_potential_impact_of_Plan_B_measures_13_October_2021.pdf (publishing.service.gov.uk)

Scientific Advisory Group for Emergencies (SAGE): Impact of false-positives and false-negatives in the UK's COVID-19 RT-PCR testing programme (3 June 2020). Report here: S0519_Impact_of_false_positives_and_negatives.pdf (publishing.service.gov.uk)

Scientific Advisory Group for Emergencies (SAGE), Vaccine Effectiveness Expert Panel (VEEP). VEEP: Vaccine effectiveness table (27 August 2021). Report here: VEEP: Vaccine effectiveness table, 27 August 2021 - GOV.UK (www.gov.uk)

SAGE paper / COVID-19 Rapid Survey of Adherence to Interventions and Responses (CORSAIR) Research and analysis overview: Testing when symptomatic, and staying at home with influenza-like illness, during autumn and winter 2021, 30 September 2021 - GOV.UK (www.gov.uk)

Scottish Annual Business Survey, Scottish Annual Business Statistics (SABS). (2018) Report here: Scottish Annual Business Statistics 2018 - gov.scot (www.gov.scot).

Scottish Government Riaghaltas na h-Alba. Coronavirus (COVID-19): modelling the epidemic in Scotland (2021). Weekly reports here: Coronavirus (COVID-19): modelling the epidemic - gov.scot (www.gov.scot)

Sheikh et al., BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant (2021) NEJM BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant | NEJM (2021)

Singanayagam, A. et al., Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study (2021) The Lancet Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases

Smith J.A.E., et al. Public health impact of mass sporting and cultural events in a rising COVID-19 prevalence in England (2021) Public Health Impact of Mass Sporting and Cultural Events in a rising COVID-19 prevalence in England (khub.net)

Smith, R.L. et al. Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection. 2021 The Journal of Infectious Diseases Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection | The Journal of Infectious Diseases | Oxford Academic (oup.com)

Tanner, R & Flood, C. M. Vaccine Passports Done Equitably. (2021) JAMA Health Forum JAMA Health Forum – Health Policy, Health Care Reform, Health Affairs | JAMA Health Forum | JAMA Network

UK Health Security Agency. COVID-19 vaccine weekly surveillance report: 11 November 2021 (week 45). Report here: COVID-19 vaccine weekly surveillance reports (weeks 39 to 45) - GOV.UK (www.gov.uk)

University of Stirling. Alcohol Focus Scotland and University of Stirling Briefing: Re-opening of hospitality - alcohol-specific risks and possible mitigation (2020). Report here: Institute for Social Marketing | Publications | About | University of Stirling

World Health Organization. WHO European Region Member State meeting on Smart Vaccination Certificate. (2021) Report here: WHO/Europe | Digital health - WHO European Region Member State meeting on Smart Vaccination Certificates (2021)